Science Explorer Back to mapMap
Discussion
Company · Murcia · Spain

Probelte Pharma (Spain)

probeltepharma.es/enROR OpenAlex
Research works
9
▼ 52% vs 2018-21
Citations
120
13.6 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
74%
world 40%
International
18%
world 18%
Probelte Pharma (Spain)

Not ranked overall: Probelte Pharma (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Probelte Pharma (Spain) work in?

In all years, 67% of research at Probelte Pharma (Spain) is in Health Sciences, 28% in Life Sciences. Its largest fields are Medicine (46%), Agricultural and Biological Sciences (23%), Nursing (17%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 66.9% of its workMedicine: 4 fractional works · 46.2% of its workImmunology and Allergy: 1 fractional works · 11.4% of its workBiochemistry: 1 fractional works · 7.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 7.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 6.3% of its workDermatology: 0 fractional works · 3.7% of its workEpidemiology: 0 fractional works · 3.7% of its workPathology and Forensic Medicine: 0 fractional works · 1.9% of its workPhysiology: 0 fractional works · 1.9% of its workSurgery: 0 fractional works · 1.9% of its workInfectious Diseases: 0 fractional works · 0.3% of its workNursing: 2 fractional works · 16.9% of its workNutrition and Dietetics: 2 fractional works · 16.9% of its workHealth Professions: 0 fractional works · 3.7% of its workEmergency Medical Services: 0 fractional works · 3.7% of its workLife Sciences: 2 fractional works · 28.0% of its workAgricultural and Biological Sciences: 2 fractional works · 23.3% of its workPlant Science: 1 fractional works · 15.5% of its workFood Science: 0 fractional works · 5.6% of its workInsect Science: 0 fractional works · 1.2% of its workAquatic Science: 0 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 2.9% of its workImmunology: 0 fractional works · 2.9% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 1.8% of its workCell Biology: 0 fractional works · 1.2% of its workMolecular Biology: 0 fractional works · 0.6% of its workPhysical Sciences: 0 fractional works · 3.2% of its workChemistry: 0 fractional works · 1.9% of its workOrganic Chemistry: 0 fractional works · 1.9% of its workEnvironmental Science: 0 fractional works · 1.2% of its workEcology: 0 fractional works · 1.2% of its workSocial Sciences: 0 fractional works · 1.9% of its workBusiness, Management and Accounting: 0 fractional works · 1.9% of its workTourism, Leisure and Hospitality Management: 0 fractional works · 1.9% of its workALL ITS WORKProbelte Pharma(Spain)9fractional works, all years
Life Sciences28%Physical Sciences3%Health Sciences67%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine446.2%
    2. Nursing216.9%
    3. Health Professions03.7%
    1. Agricultural and Biological Sciences223.3%
    2. Immunology and Microbiology02.9%
    3. Biochemistry, Genetics and Molecular Biology01.8%
    1. Chemistry01.9%
    2. Environmental Science01.2%
    1. Business, Management and Accounting01.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Probelte Pharma (Spain)?

The most cited paper from Probelte Pharma (Spain) is "Inflammasome-dependent IL-1β release depends upon membrane permeabilisation" (Fatima Martín‐Sánchez, Catherine Emma Diamond, Marcel Zeitler et al., 2016), with 288 citations. Next come "Recombinant TNFα as oral vaccine adjuvant protects European sea bass against vibriosis: Insights into the role of the CCL25/CCR9 axis" (107) and "Chemical guide parameters for Punica granatum cv. ‘Mollar’ fruit juices processed at industrial scale" (42).

Most cited papers
#PaperReleasedCitations
1 Inflammasome-dependent IL-1β release depends upon membrane permeabilisation Fatima Martín‐Sánchez, Catherine Emma Diamond, Marcel Zeitler et al. · Cell Death and Differentiation Open access 12 Feb 2016 288
2 Recombinant TNFα as oral vaccine adjuvant protects European sea bass against vibriosis: Insights into the role of the CCL25/CCR9 axis Jorge Galindo‐Villegas, Iván Mulero, Alicia García-Alcázar et al. · Fish & Shellfish Immunology Open access 9 Aug 2013 107
3 Chemical guide parameters for Punica granatum cv. ‘Mollar’ fruit juices processed at industrial scale Salud Vegara, Nuria Martí, Jose Antonio Lorente et al. · Food Chemistry Oct 2013 42
4 Toxicological evaluation of an olive extract, H35: Subchronic toxicity in the rat Jacqueline M. Heilman, Njwen Anyangwe, Nga L. Tran et al. · Food and Chemical Toxicology 13 Jul 2015 21
5 Development and characterization of an allergoid of cat dander for immunotherapy Javier Sola, Y. Pedreño, Alberto Saúl Cerezo et al. · Allergologia et Immunopathologia Open access 17 Jan 2018 8
All 17 most cited papers, with filters and sorting

Which research topics does Probelte Pharma (Spain) publish most on?

By volume in 2022-now: Pomegranate: compositions and health benefits, Phytochemistry Medicinal Plant Applications, Essential Oils and Antimicrobial Activity and Vitamin C and Antioxidants Research.

Pomegranate: composition…0Pomegranate: compositions and health benefits: 0 fractional worksPhytochemistry Medicinal…0Phytochemistry Medicinal Plant Applications: 0 fractional worksEssential Oils and Antim…0Essential Oils and Antimicrobial Activity: 0 fractional worksVitamin C and Antioxidan…0Vitamin C and Antioxidants Research: 0 fractional worksLegume Nitrogen Fixing Symbiosis: 0 fractional worksPlant Pathogenic Bacteria Studies: 0 fractional worksPlant-Microbe Interactio…0Plant-Microbe Interactions and Immunity: 0 fractional worksOcular Surface and Contact Lens: 0 fractional worksAsthma and respiratory diseases: 0 fractional worksAllergic Rhinitis and Sensitization: 0 fractional works
Nutrition and DieteticsPlant ScienceFood SciencePublic Health, Environmental and Occupational Health2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pomegranate: compositions and health benefits Nutrition and Dietetics 0 works
  2. 2 Phytochemistry Medicinal Plant Applications Plant Science 0 works
  3. 3 Essential Oils and Antimicrobial Activity Food Science 0 works
  4. 4 Vitamin C and Antioxidants Research Nutrition and Dietetics 0 works
  5. 5 Legume Nitrogen Fixing Symbiosis Plant Science 0 works
  6. 6 Plant Pathogenic Bacteria Studies Plant Science 0 works
  7. 7 Plant-Microbe Interactions and Immunity Plant Science 0 works
  8. 8 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  9. 9 Asthma and respiratory diseases Physiology 0 works
  10. 10 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.6%not open26.4%

World: 40% of research is openly available.

with international co-authors18.0%domestic only82.0%

World: 18% is written across borders.

How has Probelte Pharma (Spain)'s research output changed?

Output in 2022-2025 was 52% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Probelte Pharma (Spain) as a percentage of every work published that year, 0.0000060% in 2024.

still counting0.000020%0.000040%0.000060%Probelte Pharma (Spain)0.000013% in 20252020

Fractional works of Probelte Pharma (Spain) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Murcia

All research institutions in Murcia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Probelte Pharma (Spain). Posts are plain text and can be reported.